Six regions. One plant. Regulatory approvals held at the source.

Naprod's oncology, anesthesia, and critical-care injectables reach Latin America through direct plant-level regulatory approvals rather than distributor-only registrations. The Tarapur facility holds ANVISA (Brazil) and INVIMA (Colombia) clearances, with ANVISA renewing the plant's GMP certification in January 2026, as reported by Pharma India Magazine. Company search-console data also records demand signals from Peru.

• ANVISA , Brazil Verified

  Agência Nacional de Vigilância Sanitária (ANVISA)

• INVIMA , Colombia Verified

  Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)

• DIGEMID , Peru Being digitized

  Dirección General de Medicamentos, Insumos y Drogas (DIGEMID)

Counts pending Country-level registration counts pending confirmation. Brazil and Colombia are confirmed from the issued certificates held on file (ANVISA, INVIMA); Peru remains on the internal register and is being digitized before publication as verified.

Across Sub-Saharan and North Africa, Naprod's WHO-GMP certification anchors entry into regulatory frameworks that reference WHO-GMP-listed manufacturers. Kenya, Tanzania, Uganda, Zimbabwe, Ethiopia, and Malawi are now confirmed from the issued certificates held on file. Nigeria, Zambia, Côte d'Ivoire, and Ghana remain on the internal register and are being digitized for public verification.

• WHO-GMP Verified

  World Health Organization Good Manufacturing Practice

• NAFDAC , Nigeria Being digitized

  National Agency for Food and Drug Administration and Control

• FMHACA , Ethiopia Verified

  Food, Medicine and Healthcare Administration and Control Authority

• TFDA , Tanzania Verified

  Tanzania Food and Drugs Authority

• PPB , Kenya Verified

  Pharmacy and Poisons Board

• MCAZ , Zimbabwe Verified

  Medicines Control Authority of Zimbabwe

• PRA , Zambia Being digitized

  Zambia Medicines Regulatory Authority (formerly Pharmaceutical Regulatory Authority)

• DPM , Côte d'Ivoire Being digitized

  Direction de la Pharmacie et du Médicament

• NDA , Uganda Verified

  National Drug Authority

• FDB , Ghana Being digitized

  Food and Drugs Authority

• PMRA , Malawi Verified

  Pharmacy and Medicines Regulatory Authority (PMRA)

Counts pending Country-level registration counts pending confirmation. Kenya, Tanzania, Uganda, Zimbabwe, Ethiopia, and Malawi are confirmed from certificates on file; Nigeria, Zambia, Côte d'Ivoire, and Ghana remain on the internal register being digitized.

Gulf-region supply is anchored by direct regulatory approvals from the UAE Ministry of Health and Prevention, Bahrain's National Health Regulatory Authority, and Yemen's Supreme Board of Drugs & Medical Appliances. All three are now confirmed from certificates held on file. Company search-console data also records the United Arab Emirates among the highest-demand markets outside currently served regions.

• UAE Ministry of Health , United Arab Emirates Verified

  UAE Ministry of Health and Prevention (MOHAP)

• NHRA Bahrain , Bahrain Verified

  National Health Regulatory Authority

• Yemen SBDMA , Yemen Verified

  Supreme Board of Drugs & Medical Appliances (SBDMA)

Counts pending Country-level registration counts pending confirmation for markets beyond this set. UAE, Bahrain, and Yemen hold direct plant-level regulatory approvals confirmed from certificates on file.

Naprod holds direct regulatory approvals from the Philippines FDA and Taiwan FDA, both confirmed from certificates on file, alongside WHO-GMP standing that supports registration pathways across Southeast Asian markets recognizing WHO-GMP or PIC/S-aligned authorities. Indonesia's BPOM and Malaysia's NPRA remain on the internal register being digitized. Company search-console data records demand signals from Vietnam and Thailand.

• WHO-GMP Verified

  World Health Organization Good Manufacturing Practice

• BPOM , Indonesia Being digitized

  Badan Pengawas Obat dan Makanan

• NPRA (PIC/S) , Malaysia Being digitized

  National Pharmaceutical Regulatory Agency, a PIC/S member

• FDA Philippines , Philippines Verified

  Food and Drug Administration (FDA Philippines)

  Registrations held via local marketing-authorization holders (Multicare, RiteMed).

• Taiwan FDA , Taiwan Verified

  Taiwan Food and Drug Administration

Counts pending Country-level registration counts pending confirmation for markets beyond this set. Philippines and Taiwan are confirmed from certificates on file; Indonesia and Malaysia remain on the internal register being digitized. WHO-GMP is independently confirmed and serves as a baseline credential across the region.

Naprod holds an EAEU GMP certificate covering Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan, now confirmed from the certificate on file, materially strengthening CIS coverage alongside WHO-GMP. Ukraine's national approval (SAUMP) remains on the internal register and is being digitized. Company search-console data records demand signals from Ukraine, extending into neighboring Turkey.

• WHO-GMP Verified

  World Health Organization Good Manufacturing Practice

• EAEU GMP , EAEU Verified

  Eurasian Economic Union GMP

• SAUMP , Ukraine Being digitized

  State Administration of Ukraine on Medicinal Products

Counts pending Country-level registration counts pending confirmation. The EAEU GMP certificate (Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan) is confirmed from the certificate on file; Ukraine's national approval remains on the internal register being digitized. Turkey is tracked as a search-demand signal only, with no registration on record.

India's domestic manufacturing (Form 28B / Schedule X) and wholesale (Form 20B/21B) licences from CDSCO / Maharashtra FDA are held and current, alongside national WHO-GMP certification. Regional coverage beyond India rests on that WHO-GMP standing, which typically anchors entry into South Asian regulatory frameworks that reference WHO-listed manufacturers. Company search-console data records notable search demand from Pakistan; formal country-level registrations across the wider region are not yet documented.

• WHO-GMP Verified

  World Health Organization Good Manufacturing Practice

• CDSCO / State FDA , India Verified

  CDSCO / Maharashtra FDA

  Domestic manufacturing (Form 28B / Schedule X) & wholesale (Form 20B/21B) licences; national WHO-GMP.

Counts pending India's domestic manufacturing and wholesale licences are held and current. Country-level registration counts for markets beyond India are pending confirmation; WHO-GMP is independently confirmed and typically anchors entry into regulatory frameworks across the region. Pakistan shows recorded search-demand in company search-console data; no country-specific registration is currently on record for any other market in this region.